ARAAX
Price
$28.21
Change
+$0.10 (+0.36%)
Updated
Jun 2 closing price
Net Assets
1.61B
HCYIX
Price
$18.45
Change
+$0.05 (+0.27%)
Updated
Jun 2 closing price
Net Assets
132.69M
Interact to see
Advertisement

ARAAX vs HCYIX

Header iconARAAX vs HCYIX Comparison
Open Charts ARAAX vs HCYIXBanner chart's image
ARAAX vs HCYIX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. HCYIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a StrongBuy and HCYIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.61B vs. HCYIX (133M). HCYIX pays higher dividends than ARAAX: HCYIX (4.09) vs ARAAX (0.50). ARAAX was incepted earlier than HCYIX: ARAAX (11 years) vs HCYIX (13 years). ARAAX (1.40) is less costly to investors than HCYIX (1.26). ARAAX is a more actively managed with annual turnover of: 172.00 vs. HCYIX (92.00). ARAAX has a lower initial minimum investment than HCYIX: ARAAX (2500) vs HCYIX (50000). ARAAX annual gain was more profitable for investors over the last year : 16.70 vs. HCYIX (7.47). HCYIX return over 5 years is better than : 19.43 vs. ARAAX (14.11).
ARAAXHCYIXARAAX / HCYIX
Total Expense Ratio1.401.04135%
Annual Report Gross Expense Ratio1.401.26111%
Fund Existence11 years13 years-
Gain YTD12.3952.313536%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B133M1,208%
Annual Yield % from dividends0.504.0912%
Returns for 1 year16.707.47223%
Returns for 3 years35.1825.89136%
Returns for 5 years14.1119.4373%
Returns for 10 years57.5159.8896%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLCP24.210.25
+1.04%
Atlanticus Holdings Corp
PRMB24.660.17
+0.69%
Primo Brands Corp.
FGNX8.16-0.32
-3.83%
FG Nexus Inc
NRIX16.36-1.03
-5.92%
Nurix Therapeutics
STTK4.87-0.78
-13.81%
Shattuck Labs